MrketandMrkt

Contrast Media/Contrast Agents Market worth $5.17 Billion by 2020

Press Release   •   Aug 26, 2015 01:37 EDT

This report studies the global contrast media/contrast agentsmarket for the forecast period of 2015 to 2020. This market is expected to reach a value of $5.17 Billion by 2020, from an estimated value of $4.21 Billion in 2015, at a CAGR of 4.2% during the period under consideration.

PDF On This Report @ http://www.marketsandmarkets.com/pdfdownload.asp?id=911

The global contrast media/contrast agentsmarket has been segmented on the basis of product, route of administration, indication, procedure, application, and region.

Based on product, the contrast media/contrast agentsmarket is categorized into barium, iodinated, gadolinium, and microbubble contrast media. In 2015, the iodinated contrast media segment is estimated to account for the largest share of the contrast media/contrast agentsmarket, among products. However, the microbubble contrast media segment is expected to grow at the highest CAGR during the given forecast period.

On the basis of route of administration, the overall market has been segmented into oral, injectable, rectal, and urethral routes. In 2015, the injectable segment is expected to account for the largest share of the contrast media/contrast agentsmarket, among the different routes of administration.

Based on indication, the market is segmented into cardiovascular disorders, oncology, gastrointestinal disorders, musculoskeletal disorders, neurological disorders, and nephrological disorders. In 2015, the cardiovascular disorders segment is estimated to account for the largest share of the global contrast media/contrast agentsmarket, by indication.

On the basis of procedure, the global contrast media market is segmented into X-ray/CT, MRI, and ultrasound. In 2015, the X-ray/CT segment is expected to account for the largest share of the contrast media/contrast agentsmarket, among the procedures. However, the ultrasound segment is expected to register the highest CAGR during the given forecast period.

Furthermore, based on application, the global market has been segmented into radiology, interventional radiology, and interventional cardiology. In 2015, the radiology segment is estimated to account for the largest share of the contrast media/contrast agentsmarket, among the applications.

North America, Europe, Asia-Pacific, and Rest of the World (RoW) are the key regions considered for a geographic analysis of the global contrast media market. In 2015, North America is estimated to account for the largest share of the given market, followed by Europe and Asia-Pacific. However, the Asia-Pacific market is expected to grow at the highest CAGR during the given forecast period, and also serve as a revenue pocket for companies offering contrast media/contrast agents in the near future.

Some of the major players in the global contrast media/contrast agents market include Bayer Healthcare (Germany), GE Healthcare (U.K.), Guerbet Group (France), Bracco Imaging S.p.A. (Italy), Mallinckrodt PLC (Ireland), and Lantheus Medical Imaging (U.S.), among others.